# NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

> **NCT05354713** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** NVP-1805
- **DRUG:** NVP-1805-R1 and NVP-1805-R2

## Key facts

- **NCT ID:** NCT05354713
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-05
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-04-27
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354713, "NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05354713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*